Medtronic will pay $22 million toward the settlement of approximately 1,000 lawsuits related to the Infuse Bone Graft and is putting up to $140 million for claims that are still expected to be filed.

The Medtronic Infuse Bone Graft has been linked to serious complications when used in procedures it hasn’t been approved for, including cervical spine procedures.

The bone graft was approved in 2002 for use in lower back surgical procedures. However, it has been used in other areas such as the neck.

Lawsuits filed against Medtronic allege serious side effects from these off-label uses, and some accuse Medtronic of misleading medical professionals with regard to the safety of these uses.

Off-label uses for medical devices and pharmaceuticals are a common practice, and not illegal. However, manufacturers are not allowed to market products for off-label use.

The defective medical device attorneys at Schechter, Shaffer & Harris, L.L.P., Accident & Injury Lawyers are currently reviewing cases for Medtronic lawsuits.